sFlt-1, an antiangiogenic factor, antagonizes the activity of vascular endothelial growth factor (VEGF) and placental growth factor (PlGF), reducing their bioavailability and leading to endothelial dysfunction [6–8]. Here, PGF is linked to endothelial dysfunction.